Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma

被引:13
作者
Lian, Jiangshan [1 ]
Zhang, Xiaolin [2 ]
Lu, Yingfeng [1 ]
Hao, Shaorui [1 ]
Zhang, Zhe [3 ]
Yang, Yida [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1,Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Dept In, Hangzhou 310003, Zhejiang, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Urol Dept, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Malignant tumor; primary hepatocellular carcinoma; LncRNA-MINCR; CDK2; mRNA; clinicopathological parameters; prognosis; gene expression; CELL-PROLIFERATION; CANCER; PATHWAY; EZH2;
D O I
10.2174/1386207322666190404151020
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Objective: To investigate the expression of long-chain non-coding RNA MINCR (LncRNA-MINCR) and Cyclin-Dependent Kinase 2 (CDK2) mRNA in primary hepatocellular carcinoma, and to analyze the relationship between its expression and clinical pathological parameters and prognosis of hepatocellular carcinoma. Methods: Seventy-five surgically resected primary hepatocellular carcinoma tissues and paracancerous tissues were selected. Real-time PCR was used to detect the expression of LncRNA-MINCR and CDK2 mRNA in hepatocellular carcinoma tissues and adjacent tissues. The relationship of clinicopathological parameters and prognosis between hepatocellular carcinoma and LncRNA-MINCR and CDK2 mRNA were analyzed. Pearson correlation coefficient describes the correlation between LncRNA-MINCR and CDK2 mRNA. Results: The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma tissues was higher than that in the adjacent tissues [(5.51 +/- 0.62) vs (1.62 +/- 0.51), (4.52 +/- 0.73) vs (1.85 +/- 0.95), P<0.05]. The expression of LncRNA-MINCR in the primary hepatocellular carcinoma group was positively correlated with CDK2 mRNA (r=0.352, P<0.05), and the expression of LncRNA-MINCR in the paracancerous tissue group was not correlated with CDK2 mRNA (r=0.024, P>0.05). LncRNA-MINCR expression was associated with TNM staging, lymph node metastasis, and cirrhosis (P<0.05). CDK2 mRNA expression was associated with tumor diameter, TNM stage, lymph node metastasis, and serum alpha-fetoprotein levels (P<0.05). The 3-year survival rate of patients with high expression of LncRNA-MINCR was lower than that of LncRNA-MINCR low expression group [53.49% vs 77.38%, 2=13.024, P<0.05). The 3-year survival rate of patients with high CDK2 mRNA expression was lower than that of CDK2 mRNA low expression group [51.29] % vs 80.38%, 2 = 10.15, P < 0.05]. Conclusion: The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma tissues increased significantly. The two play a synergistic role in the invasion, invasion and metastasis of hepatocarcinoma cells. High expression of LncRNA-MINCR and CDK2 mRNA indicates poor prognosis in patients with hepatocellular carcinoma.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 14 条
[1]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[2]  
DiStefano Johanna K, 2017, Noncoding RNA Res, V2, P129, DOI 10.1016/j.ncrna.2017.11.001
[3]   MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells [J].
Doose, Gero ;
Haake, Andrea ;
Bernhart, Stephan H. ;
Lopez, Cristina ;
Duggimpudi, Sujitha ;
Wojciech, Franziska ;
Bergmann, Anke K. ;
Borkhardt, Arndt ;
Burkhardt, Birgit ;
Claviez, Alexander ;
Dimitrova, Lora ;
Haas, Siegfried ;
Hoell, Jessica I. ;
Hummel, Michael ;
Karsch, Dennis ;
Klapper, Wolfram ;
Kleo, Karsten ;
Kretzmer, Helene ;
Kreuz, Markus ;
Kueppers, Ralf ;
Lawerenz, Chris ;
Lenze, Dido ;
Loeffler, Markus ;
Mantovani-Loeffler, Luisa ;
Moeller, Peter ;
Ott, German ;
Richter, Julia ;
Rohde, Marius ;
Rosenstiel, Philip ;
Rosenwald, Andreas ;
Schilhabel, Markus ;
Schneider, Markus ;
Scholz, Ingrid ;
Stilgenbauer, Stephan ;
Stunnenberg, Hendrik G. ;
Szczepanowski, Monika ;
Truemper, Lorenz ;
Weniger, Marc A. ;
Hoffmann, Steve ;
Siebert, Reiner ;
Iaccarino, Ingram .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (38) :E5261-E5270
[4]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[5]   Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis [J].
Gopinathan, Lakshmi ;
Tan, Shawn Lu Wen ;
Padmakumar, V. C. ;
Coppola, Vincenzo ;
Tessarollo, Lino ;
Kaldis, Philipp .
CANCER RESEARCH, 2014, 74 (14) :3870-3879
[6]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
[7]   Mammalian cyclin-dependent kinases [J].
Malumbres, M ;
Barbacid, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (11) :630-641
[8]   Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells [J].
Niu, Zhaoxia ;
Liu, Huaying ;
Zhou, Ming ;
Wang, Heran ;
Liu, Yukun ;
Li, Xiayu ;
Xiong, Wei ;
Ma, Jian ;
Li, Xiaoling ;
Li, Guiyuan .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (03) :183-191
[9]   Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system [J].
Sengupta, Satyaki ;
Henry, R. William .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (10) :1289-1297
[10]   Tumor dormancy and MYC inactivation: Pushing cancer to the brink of normalcy [J].
Shachaf, CM ;
Felsher, DW .
CANCER RESEARCH, 2005, 65 (11) :4471-4474